Although there were significant changes to our policy approach in 2023, we did co-author a policy briefing with the Academy of Medical Sciences to inform an upcoming debate in Parliament on access to psilocybin treatments. We published a statement welcoming the O'Shaughnessy review and its recommendations and the emphasis it placed on the importance of clinical research in the NHS. Throughout the year we published eight Pharmacology Matters articles and a blog that centred on inclusion in Pharmacology.
Our focus in 2024 will be to expand our work to engage members, the wider pharmacology community and the public in the areas that matter to us, through the identification of core scientific and campaign priorities and through a new content strategy. This will be led through the governance structures of the Society and informed by topical and emerging themes identified through our publishing processes and Member recommendations from our events and content board.
---
Next: Dissemination cutting edge research
Previous: Bringing the pharmacological community together
Go back to Annual Review 2023